01-05-2022 | SARS-CoV-2 | Case report
Convalescent-anti-sars-cov-2-plasma/dexamethasone/remdesivir
Lack of efficacy and off label use: case report
Published in: Reactions Weekly | Issue 1/2022
Login to get accessExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event